Summary
Niklas Rindtorff is a physician-scientist and PhD student with nine years of experience building image-based profiling platforms and precision oncology tools across leading labs including the Broad Institute, DKFZ, and ETH Zurich. A Fulbright alumnus with an MSc in Biomedical Informatics from Harvard Medical School, he develops rapid, single-cell and label-free imaging approaches to predict drug vulnerabilities in patient-derived organoids. He founded LabDAO to democratize wet- and dry-lab resources and earlier launched Convexity Labs to engineer custom affinity reagents for R&D, blending entrepreneurial drive with deep translational expertise. Based in Austria, Niklas bridges clinical training (MD, summa cum laude) and computational biology, often pairing organoid culture with multi-omics and image-based screening pipelines. Notably, his work emphasizes practical, deployable platforms that accelerate drug testing directly on living tumor samples.
9 years of coding experience
3 years of employment as a software developer
MD (summa cum laude), Medicine, MD (summa cum laude), Medicine at Heidelberg University
MSc. Biomedical Informatics, Biomedical Informatics, MSc. Biomedical Informatics, Biomedical Informatics at Harvard Medical School
German, English